Client
Vivos Therapeutics
INDUSTRY
Medical Devices
Healthcare Services
DELIVERY
2023
featured services
Marketing Strategy
Project Management
Branding & Visual Identity
Event Outreach & Support
Graphic & Multimedia Design
Web Design & Development
Product, Event Photography
client bio
Vivos Therapeutics is a medical technology company that develops and commercializes non-invasive, non-surgical treatments for breathing-related sleep disorders, particularly obstructive sleep apnea (OSA) and snoring. Vivos redefines sleep care by offering FDA-cleared oral appliance therapies as a drug-free, cost-effective alternative to CPAP and surgery for patients with mild-to-severe OSA to expand access to airway-focused treatment and improve long-term health outcomes linked to sleep-disordered breathing.
CHALLENGE
Vivos Therapeutics was undergoing rapid expansion and required scalable creative support to produce high volumes of print, web, event, and outbound marketing collateral across its core brand and multiple subsidiaries. The company also needed a centralized, efficient ticketing system to manage creative requests, track ROI analytics, and ensure consistent value delivery across all business units.
APPROACH
Creative Sweetie spearheaded end-to-end strategy and execution, leading a multidisciplinary team of content, web, graphic design, video/photo, and marketing specialists to support Vivos’ subject matter experts in their outbound campaigns. These measures drove increased event and web traffic, refined lead generation efforts, and solidified Vivos’ position as an industry leader through the development and widespread distribution of key thought leadership assets.
RESULTS
Creative Sweetie became an embedded extension of the Vivos team, delivering strategic guidance and fulfillment services to executive stakeholders while providing on-the-ground support at seminars, webinars, and industry conferences. We also built a comprehensive, templatized library of on-brand sales enablement and marketing assets designed to serve Vivos and advance its mission for years to come.
EXPLORE MORE
